African American Women Who Receive Primary Anthracycline- and Taxane-Based Chemotherapy for Triple-Negative Breast Cancer Suffer Worse Outcomes Compared With White Women

Lignende værker

• Racial Disparities in the Rate of Cardiotoxicity of HER2- Targeted Therapies Among Women with Early Breast Cancer
  af: Litvak, Anya, et al.
  Udgivet: (2018)
• The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy
  af: Hilaj, Erina, et al.
  Udgivet: (2020)
• Feasibility Trial of Partial Breast Irradiation With Concurrent Dose-Dense Doxorubicin and Cyclophosphamide in Early-Stage Breast Cancer
  af: Zellars, Richard C., et al.
  Udgivet: (2009)
• Treatment Options for Breast Cancer Resistant to Anthracycline and Taxane
  af: Moreno-Aspitia, Alvaro, et al.
  Udgivet: (2009)
• A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer
  af: Higgins, Michaela J., et al.
  Udgivet: (2011)